IGC PHARMA, INC. (IGC) Operating income 2016–2025
IGC PHARMA, INC. (IGC) annual operating income history from SEC filings — each fiscal year as reported.
-$7.4MFY2025 · since FY2016: -$2.9M → -$7.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.4M | +24.0% |
| FY2024 | -$9.8M | +15.3% |
| FY2023 | -$11.6M | +25.0% |
| FY2022 | -$15.4M | -76.8% |
| FY2021 | -$8.7M | -27.1% |
| FY2020 | -$6.9M | -47.8% |
| FY2019 | -$4.6M | -159.5% |
| FY2018 | -$1.8M | +12.9% |
| FY2017 | -$2.1M | +29.3% |
| FY2016 | -$2.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice